These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 25605418)
41. Analysis of urine cytology at a community hospital. Mansoor I J Ayub Med Coll Abbottabad; 2003; 15(2):20-3. PubMed ID: 14552242 [TBL] [Abstract][Full Text] [Related]
42. Does subdivision of the "atypical" urine cytology increase predictive accuracy for urothelial carcinoma? Bostwick DG; Hossain D Diagn Cytopathol; 2014 Dec; 42(12):1034-44. PubMed ID: 24838797 [TBL] [Abstract][Full Text] [Related]
43. BTA TRAK urine test increases the efficacy of cytology in the diagnosis of low-grade transitional cell carcinoma of the bladder. Gibanel R; Ribal MJ; Filella X; Ballesta AM; Molina R; Alcaraz A; Alcover JB Anticancer Res; 2002; 22(2B):1157-60. PubMed ID: 12168917 [TBL] [Abstract][Full Text] [Related]
44. Novel photodynamic diagnosis of bladder cancer: ex vivo fluorescence cytology using hypericin. Olivo M; Lau W; Manivasager V; Bhuvaneswari R; Wei Z; Soo KC; Cheng C; Tan PH Int J Oncol; 2003 Dec; 23(6):1501-4. PubMed ID: 14612919 [TBL] [Abstract][Full Text] [Related]
45. The effects of the current World Health Organization/International Society of Urologic Pathologists bladder neoplasm classification system on urine cytology results. Curry JL; Wojcik EM Cancer; 2002 Jun; 96(3):140-5. PubMed ID: 12115301 [TBL] [Abstract][Full Text] [Related]
46. The clinicopathologic correlates of cellular atypia in urinary cytology of ileal neobladders. Cimino-Mathews A; Ali SZ Acta Cytol; 2011; 55(5):449-54. PubMed ID: 21986173 [TBL] [Abstract][Full Text] [Related]
47. Neural network using combined urine nuclear matrix protein-22, monocyte chemoattractant protein-1 and urinary intercellular adhesion molecule-1 to detect bladder cancer. Parekattil SJ; Fisher HA; Kogan BA J Urol; 2003 Mar; 169(3):917-20. PubMed ID: 12576812 [TBL] [Abstract][Full Text] [Related]
48. The use of urinary nuclear matrix protein 22 (NMP22) as a diagnostic adjunct to urine cytology for monitoring of recurrent bladder cancer--institutional experience and review. Önal B; Han Ü; Yilmaz S; Köybasioglu F; Altuğ U Diagn Cytopathol; 2015 Apr; 43(4):307-14. PubMed ID: 25488052 [TBL] [Abstract][Full Text] [Related]
49. Early diagnosis and monitoring of superficial transitional cell carcinoma by microsatellite analysis on urine sediment. Bartoletti R; Dal Canto M; Cai T; Piazzini M; Travaglini F; Gavazzi A; Rizzo M Oncol Rep; 2005 Mar; 13(3):531-7. PubMed ID: 15706429 [TBL] [Abstract][Full Text] [Related]
50. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma. Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536 [TBL] [Abstract][Full Text] [Related]
51. The fate of an unsatisfactory urine cytology test among patients with urothelial carcinoma. Ordon M; Boerner S; Zlotta AR; Jewett MA; Fleshner N BJU Int; 2009 Dec; 104(11):1641-5. PubMed ID: 19583723 [TBL] [Abstract][Full Text] [Related]
53. Fluorescence in situ hybridization assay detects upper urinary tract transitional cell carcinoma in patients with asymptomatic hematuria and negative urine cytology. Huang WT; Li LY; Pang J; Ruan XX; Sun QP; Yang WJ; Gao X Neoplasma; 2012; 59(4):355-60. PubMed ID: 22489689 [TBL] [Abstract][Full Text] [Related]
54. Impact of different grades of microscopic hematuria on the performance of urine-based markers for the detection of urothelial carcinoma. Todenhöfer T; Hennenlotter J; Tews V; Gakis G; Aufderklamm S; Kuehs U; Stenzl A; Schwentner C Urol Oncol; 2013 Oct; 31(7):1148-54. PubMed ID: 22130125 [TBL] [Abstract][Full Text] [Related]
55. uCyt+/ImmunoCyt and cytology in the detection of urothelial carcinoma: an update on 7422 analyses. Comploj E; Mian C; Ambrosini-Spaltro A; Dechet C; Palermo S; Trenti E; Lodde M; Horninger W; Pycha A Cancer Cytopathol; 2013 Jul; 121(7):392-7. PubMed ID: 23495066 [TBL] [Abstract][Full Text] [Related]
56. Gene expression signature in urine for diagnosing and assessing aggressiveness of bladder urothelial carcinoma. Mengual L; Burset M; Ribal MJ; Ars E; Marín-Aguilera M; Fernández M; Ingelmo-Torres M; Villavicencio H; Alcaraz A Clin Cancer Res; 2010 May; 16(9):2624-33. PubMed ID: 20406841 [TBL] [Abstract][Full Text] [Related]
57. Urinary cytology has a poor performance for predicting invasive or high-grade upper-tract urothelial carcinoma. Messer J; Shariat SF; Brien JC; Herman MP; Ng CK; Scherr DS; Scoll B; Uzzo RG; Wille M; Eggener SE; Steinberg G; Terrell JD; Lucas SM; Lotan Y; Boorjian SA; Raman JD BJU Int; 2011 Sep; 108(5):701-5. PubMed ID: 21320275 [TBL] [Abstract][Full Text] [Related]
58. Expression of cytokeratin 20 in urine cytology smears: a potential marker for the detection of urothelial carcinoma. Bhatia A; Dey P; Kumar Y; Gautam U; Kakkar N; Srinivasan R; Nijhawan R Cytopathology; 2007 Apr; 18(2):84-6. PubMed ID: 17397492 [TBL] [Abstract][Full Text] [Related]
59. The reliability of urinary cytology in the detection of tumours of urinary bladder. Mondal A; Banerjee DK J Indian Med Assoc; 1992 Oct; 90(10):265-7. PubMed ID: 1287085 [TBL] [Abstract][Full Text] [Related]
60. [Tree analysis pattern of mass spectral urine profiles in differential diagnosis of bladder transitional cell carcinoma]. Wu DL; Zhang YF; Guan M; Liu WW; Xu YM; Jin SB; Zhang J; Jin CR; Lü Y Zhonghua Zhong Liu Za Zhi; 2007 Apr; 29(4):274-7. PubMed ID: 17760254 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]